Sub-section menu :

Content :

2017

Communication / Conference: Counterfeit Fentanyl has invaded the United States these two last years causing multiple fatalities

France - 02 October 2017

Source: Partnership for Safe Medicines


In a report issued by The Partnership for Safe Medicines in September 2017, we can see the terrible scourge of counterfeit medicines containing the deadly ingredient fentanyl, most often illegally imported, that have impacted 40 States in the past two years. These drugs are tied to deaths in more than a dozen states.


Counterfeit pills made with fentanyl are made into fake opioids, like OxyContin, but they are also now made into fake Xanax and non-opioid pill shapes.


"There is a global counterfeit drug crisis, and this is a lucrative business for counterfeiters who are buying cheap, illegal fentanyl from Chinese suppliers and shipping it into the U.S., often via the mail," said Dr. Marvin Shepherd, chairman of the PSM Board and former director of the Center for Pharmacoeconomic Studies at the University of Texas at Austin’s College of Pharmacy.


Report: Counterfeit Medications Containing Deadly Fentanyl Have Been Found in 40 States, issue September 25, 2017.


Counterfeit Fentanyl has invaded the United States these two last years causing multiple fatalities
Photo : The Partnership for SafeMedicines

Internet: In France, 1.4 metric tons of health products were seized during Operation PANGEA X

France - 26 September 2017

Sources: Interpol et ANSM (in French)


The Operation Pangea is the biggest law enforcement operation on the Internet. In 2017 and for the 10th edition, 433,000 illicit health products and 1.4 metric tons of bulk health products were seized by customs during the operation. Most of these products were drugs without French market authorization, drugs turned from their legitimate purpose and sold for their narcotic or sports doping effects (steroids, growth hormones, etc.) or creams meant to whiten skin. A number of bulk active pharmaceutical ingredients were also discovered. More than 70% of the seized products came from Asia (primarily India and Singapore).


A total of 185 illegal websites of illicit drugs have been identified during this operation.


Over its ten-year history, Operation Pangea has seized more than 85 million illegal products and closed more than 67,000 illicit online pharmacies.

Internet: Operation PANGEA X closes 3,584 illicit websites and seizes 25 million potentially dangerous medications

France - 25 September 2017

Sources: Interpol et ANSM (in French)

The Operation Pangea – coordinated by Interpol - is the largest annual repression program targeting the illegitimate sale of medicines on the Internet. The tenth edition of Operation Pangea, held from 12 to 19 September 2017, benefited from the participation of close to 200 law enforcement agencies, customs services, drug regulatory bodies, and private companies—including Sanofi—from 123 countries. The world over, Pangea X resulted in the arrest of 400 people and the record seizure of 25 million potentially dangerous medicines valued at more than US$51 million. Among the seized products were food supplements, painkillers, epilepsy medications and erectile dysfunction treatments.

Moreover, this year's operation discovered counterfeited medical devices such as dentistry materials or preservatives, and, importantly, counterfeited opioids, fentanyl in particular. Fentanyl is a powerful narcotic and counterfeits of it have been implicated in thousands of cases of overdose and death worldwide over the last few years.

In all, 1,058 investigations were carried out for Pangea X and 3,584 websites closed. Also, more than 3,000 advertisements for illicit pharmaceuticals were removed from the Internet.

Operation PANGEA X closes 3,584 illicit websites and seizes 25 million potentially dangerous medications
Photo : ©Interpol

Legislation: MEDICRIME Convention ratified by Turkey

Europe - 21 September 2017

Edqm.eu


On 21 September 2017, Turkey became the eleventh State to ratify the Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health, also known as the MEDICRIME Convention. The Convention will come into force in Turkey on 1 January 2018.


The MEDICRIME Convention is the first international treaty against the falsification of medical products and similar crimes. It offers a legal framework for worldwide cooperation in prosecuting pharmaceutical crimes posing a global threat to public health. Opened for signature and ratification since October 2011 to all the countries of the world, 27 Member States and non-Members have signed the MEDICRIME Convention, and 11 countries have ratified it.


MEDICRIME Convention ratified by Turkey

Legislation: Ratification of the MEDICRIME Convention by Burkina Faso

Europe - 27 July 2017

Council of Europe


On July 27, 2017, Burkina Faso is the tenth country to have ratified the Council of Europe's MEDICRIME Convention.
Africa is one of the continents most affected by the trafficking of fake medicines. West African countries have recently signed the Convention, such as Guinea, Ivory Coast and Benin, thus demonstrating their willingness to tackle this crime and to establish genuine legal levers.


The MEDICRIME Convention is the first international treaty against the falsification of medical products and similar crimes. It offers a legal framework for worldwide cooperation in prosecuting pharmaceutical crimes posing a global threat to public health. Opened for signature and ratification since October 2011 to all the countries of the world, the MEDICRIME Convention counts to date: 27 countries signatories (Member States and non-Members) and 10 countries have ratified it.


For Burkina Faso, the Convention will enter into force on 1 November 2017.


Signatures and ratification of Medicrime convention

Travel Tips App: Protect your health when travelling abroad and avoid fake medicines

Available on mobile platforms, the "Travel Tips" application should be essential when travelling abroad. Attractive and easy to use, the App is built around advice for travelers and educational quiz.

Click HERE to learn more and download for free the application.


Protect your health when travelling abroad and avoid fake medicines

Communication / Conference: Fake Harvoni uncovered in legal medicine supply chain in Germany

Germany - 20 June 2017

BfArM


The German Federal Institute for Drugs and Medical Devices (BfArM) recently discovered counterfeit Harvoni, after a patient identified tablets as fake thanks to their color: genuine Harvoni tablets are orange while the tablets received by the patient were white. He then raised the alarm, enabling BfArM to intervene. The Institute said all other aspects of the medicine and its packaging, including the batch number and tablet form, match the features of genuine packs of Harvoni. Officials are now investigating on the tablets entry in the legitimate supply chain, and screening is underway to ascertain which ingredients they contain.

Legislation: MEDICRIME Convention is about to be signed by Benin

Benin - 20 June 2017

Benin Times


The MEDICRIME Convention is the first international treaty against falsification of medical products and similar crimes. It offers a legal framework for worldwide cooperation in prosecuting pharmaceutical crimes posing a global threat to public health. To date, 18 countries (member and non-member states of the Council of Europe) have signed the MEDICRIME Convention and 9 have ratified it.


In June 2017, the bill was adopted at the National Assembly of Benin for authorization to sign and ratify the MEDICRIME Convention of Council of Europe. According to Deputy Valère Tchobo, fake drugs are sold on the black market and in real pharmacies alike, and the convention should help in the fight against counterfeit drugs.


A new brochure was published containing all the information needed to know about the Convention. Discover the new MEDICRIME brochure



MEDICRIME brochure

Internet / Enforcement: 6 Canadians arrested for selling fake cancer drugs online

Canada - 19 June 2017

CBC News


Six Canadian men have been arrested in U.S. extradition Act, in connection with an international internet drug investigation involving the distribution of counterfeit cancer drugs. U.S. federal prosecutors have accused the president and founder, CanadaDrugs.com and affiliated companies and associates in the United Kingdom and Barbados of illegally importing and selling USD 78 million worth of unapproved new drugs, misbranded drugs and counterfeit drugs to American doctors between 2009 and 2012.

Communication / Conference: In China, new rating system to evaluate pharmacies

China - 16 June 2017

Sina Med


The Market Supervision Bureau of Penglai city, in Shandong Province, is preparing a system to evaluate local pharmacies. According to this program, they will be granted a grade: from A for “Trustworthy” to D for “Serious unworthiness”. Depending on the grade obtained, inspections would be more or less frequent, up to 4 inspections a year for D-graded pharmacies. This plan is to be developed nationwide, and county, municipal, provincial and national level Food and Drugs Departments’ databases should be interconnected in 2019-2020, making it difficult for the pharmacies that were graded D to move elsewhere.

Enforcement: Crackdown on counterfeit Hepatitis C drugs in Egypt

Egypt - 15 June 2017

Egypt Independent


The Egyptian Administrative Control Authority (ACA) arrested a group of people, accused of selling imitations of Hepatitis C treatments and imitations of drugs treating infections and chronic pain. During this operation, ACA closed an unlicensed pharmaceutical company and 5 affiliated offices, seized thousands of forged drug packages, the material used to manufacture the forged products, and arrested 3 people.

Enforcement: New marking system to fight against counterfeiting

Russia - 15 June 2017

Komsomolskaya Pravda 


On 1 June 2017, the Department of Revenue and the Federal Service for Surveillance in Healthcare (Roszdravnadzor) launched a system to clean the drug market from counterfeits: in pharmacies, the customer will be able to scan any drug and check all its information value chain, thanks to a special mark stamped on it. This system, which costs RUB 630 million (USD 10.63 million), was previously successfully tested on fur coats and was almost instantly profitable: customs duties went up RUB 500 million (USD 8.43 million). According to experts, 1% to 15% of the drug market would be made up with counterfeits or damaged products.

Internet: Brazil removes 1,503 irregular online medicines advertisements in 2017

Brazil - 12 June 2017

Encontro


The Brazil Sanitary Surveillance Agency (ANVISA) announced that, for the first six months of 2017, it removed 1,503 irregular announcements for medicine products, including counterfeit drugs and products such as Ritalin and Sibutramine, which can only be sold in pharmacies. The number of irregular announcements identified increased: 1,293 were removed in 2016, and 657 in 2015.

Communication / Conference: Czech authorities worried by E-commerce of fake drugs

Czech Republic - 08 June 2017

Fondation Chirac


E-commerce is a very popular practice in the Czech Republic, and people are increasingly making use of it to buy medicines. But in this country, as in others, fake medicines and falsified food supplements are acquiring an ever-greater number online, and seriously threatening patients’ health. Facing this growing phenomenon, the State Institute for Drug Control is launching an alert, encouraging the population to consult authorized and certified online pharmacies only. A specific website was created to inform patients about the involved risks, and to report fraudulent websites and suspicious remedies. According to the first analyses, many of them would come from Thailand, and would not be authorized to be sold in the Czech Republic.

Communication / Conference: WHO issues warning against a falsified vaccine to treat meningitis discovered in Niger

Niger - 07 June 2017

WHO


On May 31, the World Health Organization announced that a falsified version of a "Polysaccharide Meningococcal ACWY Vaccine" improperly labelled as being produced by the manufacturer "Bio-Manguinhos/Fiocruz" was circulating in Niger. So far, the Ministry of Health announced and seized one lot of this falsified vaccine, and an enquiry was pending to determine the quantity and the origin of the counterfeit vaccines introduced in the country.

  • WHO - Medical Product Alert N° 1/2017

Falsified Meningococcal ACWY Vaccine circulating in West Africa

Falsified Meningococcal ACWY Vaccine circulating in West Africa
Credit: WHO


Communication / Conference: Sanofi participates in the 2017 World Anticounterfeiting Day dedicated to medicines

France - 07 June 2017

Unifab


Unifab (Union des Fabricants) held the 20th edition of World Anticounterfeiting Day on 7 June 2017. This year's event spotlighted counterfeit drugs, which have topped the list of the largest seizures made by French Customs over the past three years. And topping the list gives impressive numbers: with more than 2.5 million fake products intercepted, the drug sector is particularly affected by counterfeiting.

Sanofi and other French laboratories participated in the event in the good company of several national and international personalities. LEEM Director Philippe Lamoureux underlined that France is often used as a transit zone and thus not spared from counterfeiting. Pharmaceutical crime uses all possible vectors, including the online sale of medicines.

Speaking to an audience of nearly 200 people, Geoffroy Bessaud, the Head of Anti-Counterfeiting Coordination at Sanofi, explained how the Central Anticounterfeiting laboratory (LCAC) at the Sanofi Tours site analyzes falsified drugs from around the world (more than 2600 products in 2016) and how Sanofi protects patients from unsure products. "Through the coordination of healthcare actors for the deployment of these sophisticated technologies, we can collectively continue to improve our efforts to protect patients from falsified medicines", he concluded.


Sanofi participates in the 2017 World Anticounterfeiting Day dedicated to medicines

Credit : Unifab

Enforcement: More than 430,000 pills intercepted in illegal circuit in Portugal

Portugal - 03 June 2017

Publico


The National Drug Authority (Infarmed), in cooperation with the Tax and Customs Authority (AT), intercepted a total of 15,532 packages in the illegal drug circuit representing 436,686 units (as tablets or sachets). The figures are lower than those detected in 2015 as 25,306 packages and 619,980 units had been retained or returned. The main part of the illegal drugs are purchased online and shipped from countries such as United-States, not directly from the production sites.

Legislation: New US bill for tougher penalties for counterfeit medicines

United States - 01 June 2017

Congress.gov and Securing Industry


A new bill (the Drug Diversion and Counterfeit Crackdown Act of 2017), introduced in May, looks to amend the Federal Food, Drug and Cosmetic Act, so that the penalties dished out to conmen counterfeiting medicines are on a par with criminals who divert legitimate drugs. This would aim at reducing the discrepancy currently existing between the two crimes, as a person guilty of producing and distributing counterfeit drugs in the US cannot be jailed for more than one year, nor fined more than USD 1,000, whereas diverting US-made drugs for foreign markets back into the US can lead to a 10-year prison sentence, and fines reaching USD 250,000.


H. R. 2376 - To amend the Federal Food, Drug, and Cosmetic Act to protect and strengthen the drug supply chain in the United States by closing several statutory gaps in the penalty provisions of such Act that apply to drug diversion and counterfeiting.

Communication / Conference: Warning about counterfeit anti-cancer drugs with fake labels in Iran

Iran - 31 May 2017

Salamat News


Homayoun Hashemi, a member of the Parliamentary Health Committee, warned about the development of the sale of fake anti-cancer drugs with fake labels in the country. He then strongly criticized the lack of official supervision in the field of counterfeit medicines.

Communication / Conference: New WHO term for falsified medical products

International - 29 May 2017

WHO


The term "substandard and falsified (SF) medical products" was adopted at the 17th World Health Assembly of the World Health Organization (WHO) held 29 May 2017 in Geneva. It replaces the previous term of "substandard/spurious/falsely-labelled/falsified/counterfeit medical products". Falsified is now used to refer to items posing a risk for public health, whereas "counterfeit" is now reserved for intellectual property issues.

The WHO communiqué states that falsified medical products are those "that deliberately/fraudulently misrepresent their identity, composition or source".

New WHO term for falsified medical products

Technology: In Brazil, national drug tracking system launched in August

Brazil - 29 May 2017

Correio Braziliense


The National Health Surveillance Agency (ANVISA) announced that a new national drug tracking system would start being tested in August, for one year. In its first stage, the system will include 5 types of medicines. The tracking system that will be fully set in 2022 will be narrower than imagined in 2009, when the law was initially adopted, and will not include the drugs distributed through the Unified Health System, nor those provided by the tuberculosis and AIDS programs. For ANVISA, the priority is to target medicines likely to be counterfeited and widely used, such as antibiotics or drugs for hypertension and diabetes. A first version of the regulation regarding the implementation of this test system has been published by ANVISA, and will be amended in the following months.

Communication / Conference: Activities on counterfeit drug prevention organized by the China FDA

China - 26 May 2017

CFDA


In the frame of the Science and Technology Week in China, the China Food and Drug administration organized a series of activities in Beijing and several other Chinese locations, themed “Food safety, innovation and dreams”. FDA officers especially focused in raising public awareness about the risks of counterfeit drugs, and the methods to distinguish genuine and counterfeit medicines. The activities were organized in Hainan, Gansu, Guizhou, Guangxi, Inner Mongolia, Shaanxi and Jilin provinces.

Communication / Conference: More training to struggle against counterfeit drugs in Algeria

Algeria - 17 May 2017

Algérie Eco


In the frame of the 18th International Pharmaceutical Forum organized in Alger on May 15th, 2017, Djamel Brika, Director of the public relations department at the General Directorate of the Algerian Customs, explained that customs officers did not received any specific training to recognize the counterfeit drugs, which is an especially difficult task. M. Brika asked to the medicine manufacturers to invite custom officers to visit their premises, to acquire the knowledge required to determine if a drug is counterfeited or not. M. Birka also explained that, for example, important amounts of drugs were seized at Tébessa and at Tamanrasset in the South of the country, but that it was not possible to ascertain if the drugs were genuine or not.

Algerian Customs seized 17,272 boxes of counterfeit drugs in 2016, for a total value of DZD 1.2 million (USD 11,059) and, since 2017, they opened 9 cases concerning 13,809 units.

Communication / Conference: Sanofi raises public awareness on fake medicines for France-Colombia year

Colombia - 17 May 2017

Année France-Colombie (in French) and Ambassade de France (in French)


Sanofi is a partner of the 2017 France-Colombia Year, launched 16 December 2016. The first half-year "season" (16 December to 14 July) will celebrate France in Colombia and the second (23 June to 16 December) Colombia in France. According to the website of the French Embassy in Bogota, the objective of France-Colombia Year is to "accompany the country's profound transformation and international projection efforts to renew and improve its image in France and Europe".

Within this setting, a forum entitled "Pharmaceutical Crime: Issues and Threats for Public Health" was held in Bogota on 17–18 May 2017. The forum aimed at developing the exchange of French and Colombian experiences to optimize the war on counterfeit medicines and strengthen the protection of public health in partnership with Sanofi. The French Embassy in Bogota and the Secretariat for Transparency of the Presidency of the Republic of Colombia participated in the organization of the event, which united an audience of 160 French authorities, Colombian authorities and experts from pertinent fields.


Sanofi raises public awareness on fake medicines for France-Colombia Year
The ambassador of France in Colombia, Jean-Marc Laforet during the Forum.

Communication / Conference: Fighting counterfeit drugs - A new study carried out by Sanofi in Latin America finds high public awareness, but a mixed perception of dangers

Latin America - 17 May 2017

Sanofi


Sanofi has been working to prevent and fighting fake medicines for nearly 10 years. This counterfeiting problem is most acute in Asia, Africa and Latin America, where it is easier to evade controls on distribution channels. In those regions, counterfeit drugs can represent up to 30% of the market.

The Internet has also become a major vector for counterfeit trafficking. For example, according to WHO, counterfeits account for 50% of medicines sold on websites that conceal their physical addresses.

Sanofi, as a partner of the 2017 France-Colombia Year, carried out a study on the perception of counterfeit medicines in Latin America: Read the press release and the study results here.


Fighting counterfeit drugs

Communication / Conference: 16% of US counterfeit goods seized involve pharmaceuticals

United States - 16 May 2017

PharmTech.com


According to the United States Trade Representative (USTR)’s 2017 Special 301 Report, published in May 2017, 16% of the 31,560 US government seizures of counterfeit goods in 2016 involved pharmaceuticals. 90% of counterfeit pharmaceuticals seized came from China (including Hong Kong), India, and Singapore. US customs authorities have been working with their counterparts around the world, and most recently, with Singapore and China, to prevent counterfeit pharmaceutical sales in the US. For instance, in April, 2016, a month-long operation with China resulted in over 1,400 seizures of counterfeits, including some pharmaceuticals, while a cooperative program with Singapore was launched in August, 2016.

Enforcement: Two suspects held in custody for selling fake pig vaccines in Taiwan

Taiwan - 16 May 2017

Focus Taiwan


Two suspects have been arrested on suspicion of supplying pig farmers with fake vaccines. The counterfeit vaccines were supplied by a man who was selling them at TWD 63 (USD 2.07) per dose through a middleman, according to a statement issued by the Yunlin District Prosecutors Office on May 15. They said the two suspects have earned at least TWD 25 million (USD 821,386) with this fraud. Pig farmers were duped because the vaccines carried labels and trademarks, and were accompanied by a fake but official-looking certificate of authenticity.

Communication / Conference: 95% drugs advertised in satellite channels and cyber space would be counterfeit in Iran

Iran - 11 May 2017

Iranian Students' News Agency (ISNA)


Iranian drug expert, Mohammad Baghaei, is concerned about the figure of 95% of the drugs being sold through satellite channels ads broadcasted in Iran and cyber space are counterfeit. Many of them pretend they are approved by the American FDA or by the Iranian Ministry of Health, whereas they are not.

Enforcement: 40 tons of fake medicines seized during a market breakup in Abidjan

Ivory Coast - 04 May 2017

news.abidjan.net


On 3 June 2017, Ivory Coast authorities dispatched 700 police officers to break up a fake drugs market at Adjamé-Roxy, in Abidjan, and seized 40 tons of counterfeit products. This market was supposed to supply nearly a third of all treatments sold in the country. According to a local association of pharmaceutical retailers, such "street pharmacies" cost the country's legal pharmaceutical sector XOF 40 to 50 billion (USD 69,261,900 to 86,577,300) each year, including XOF 5 billion (USD 8,657,730) of lost revenue for the government. On March 10, the authorities had already incinerated 50 tons of falsified drugs worth EUR 1 million (USD 1,135,820).


Following this early-June operation, the Ministry of Health announced that the authorities were realizing a long term operation and running several awareness campaign targeting the 8,000 women involved in illegal drug.

Communication / Conference: In Ukraine, up to 50% of the drugs could be counterfeit

Ukraine - 27 April 2017

Gorod Kh


According to experts of the pharmaceutical industry, the number of counterfeit drugs traded in Ukraine pharmacies goes up steadily, covering all kind of drugs from antiseptics to anticancer drugs. Hence, in 2016, the administration issued 31 orders prohibiting the trade of 21 counterfeit drug brands, and during the first three months of 2017, six brands were prohibited. According to the head on the Internet project « Medicine Control », around 1% of the drugs in Ukraine are counterfeit, but according to a pediatrician in Kharkov the number could amount to 50%.

Communication / Conference: Creation of a system to curb the counterfeit drugs

Caribbean region - 12 April 2017

Securing Industry


A new regulatory system (Caribbean Regulatory System, CRS) was established in the Carribean region to provide registration, product reviews and pharmacovigilance support to Caribbean Community and Common Market (CARICOM) members. The CRS was established by the Caribbean Public Health Agency (CARPHA), in collaboration with CARICOM, the World Health Organization, the Pan American Health Organization, and with support from the Bill and Melinda Gates Foundation. The CRS should contribute to tackle the presence of counterfeit and substandard drugs in this region of 17 million people where, according to some reports, the counterfeit market share could reach 30% of the pharmaceutical market.

Legislation: Burkina Faso signs the Medicrime Convention

Burkina Faso - 16 February 2017

Coe.int


On February 16th, 2017, Burkina Faso was the 27th State to sign the « Medicrime Convention » (Convention of the Council of Europe on counterfeit medical products and similar offences threatening public health). This Convention is the only international tool criminalizing the counterfeiting of medical products and similar offences that might have an effect on patients’ health.

Communication / Conference: A death due to counterfeit anti-cancer drug in the United States

United States - 02 February 2017

The Partnership for Safe Medicines


In 2011, a woman died in Arizona of advanced stage lung cancer. She was treated with counterfeit Avastin. In a Danish documentary “Lethal Fake Medicine / Medicin der Dræber”, FDA-OCI investigator Dan Burke describes what happened to her:

“This is a case involving counterfeit Avastin, which is a cancer medication. That case really started with a victim, a woman who went into an oncology clinic and had a reaction to the Avastin. And we come to find out it wasn’t Avastin at all, it was labeled Altzuan, which is a Turkish version, and we found out that it did not contain the active pharmaceutical ingredient.”

The Food and Drug Administration (FDA) raided the doctor’s office which they determined was water and mold. The doctor was informed that she had purchased counterfeit drugs.

In January 2014, Ozkan Semizoglu and Sabahaddin Akman of Ozay Pharmaceuticals were sentenced to 30 months in prison for their role in delivering fake cancer drugs to illicit suppliers based in Canada.

Communication / Conference: Hospitals treated children with counterfeit chemotherapy drugs in Mexico

Mexico - 27 January 2017

The Partnership for Safe Medicines


An investigation into the corruption of former Governor Javier Duarte has uncovered allegations that children with cancer were treated in state-run hospitals in Veracruz with counterfeit chemotherapy medicines due to budget shortfalls and lack of resources caused by his administration. The BBC reports, that when tested, the counterfeit chemotherapy drugs came back as an inert compound. It was essentially distilled water.

Current Governor Miguel Angel Yunes Linares said, “This seems to us a brutal crime, an attempt against the lives of the children.” Authorities have lab tests results that were performed by Roche Laboratories dating back to 2010 to prove the use of fake chemotherapy drugs. According to Telesur, Prosecutors allege that Duarte embezzled or misspent as much as US $2 billion since he took office nearly six years ago.

An investigation is underway and Governor Yunes Linares has said a legal complaint will be filed when it is completed.

Communication / Conference: A new interception operation in 16 countries in Africa allows the seizure of 113 million illicit pharmaceutical products

International - 20 January 2017

January 20th, 2017 - IRACM and WCO


On January 20, 2017, IRACM (International Institute of Research Against Counterfeit Medicines) and WCO (World Customs Organization) organized a media breakfast in Paris to unveil the results of ACIM operation (Action against Counterfeit and Illicit Medicines) and presented the ongoing evolutions of traffickers’ practices such as fraud routes, concealment methods, or classes of medicines. This is a new record seizure of 113 million illicit and potentially dangerous pharmaceutical products which took place in September 2016.


Operation ACIM mobilized 16 African customs administrations over a ten-day period, from 5 to 14 September 2016, to inspect simultaneously, in the main ports on the continent, cargoes identified as likely to contain illicit or counterfeit pharmaceutical products posing a dangerous threat to local populations. Most treatments were: antimalarial drugs, anti-inflammatories, antibiotics, and analgesics, as well as gastro-intestinal medicines.


ACIM Operation

Internet: Fake ads removed by Google

International - 17 January 2017

localfresh.com


In 2016, Google removed over 1.7 billion ads worldwide, and banned more than 200 websites from the company’s AdSense network, due to the growth of misleading content. The company reported that it disabled over 68 million ads in 2016 for healthcare violations, and specifically limits the promotions of pharmaceutical drugs on their AdSense network. Their AdSense policy states that ads cannot contain content related to the online sale of prescription drugs or the sale of unapproved supplements.

Legislation: New rules regarding the sale of drugs by online pharmacies to come into effect in Russia

Russia - 12 January 2017

nsn.fm


The new rules for the sale of drugs by online pharmacies will come into force in October 2017 according to a document published by the Ministry of Health on the official portal of legal information. The new amendments added to the law aim at combating counterfeit products and must also help controlling the pharmaceuticals prescriptions.

It is currently is forbidden to sell drugs online in Russia, but the legalization of this market segment is scheduled for October 2017.

Legislation: A new law approved to combat counterfeiting in the United Arab Emirates

United Arab Emirates - 02 January 2017

Gulfnews.com


A new law aimed at fighting against counterfeit goods and commercial fraud was approved by United Arab Emirates autorities in December 2016. The law notably empowers the court to order confiscation or destruction of food, medical drugs, crops and tools, and anyone deceiving or attempting to deceive another party by fraud of such products may be punished.
The law takes effect immediately. The maximum sentence can be up to 2 years imprisonment and a fine of up to 1 million dirahmas of UAE, or more than US$272,000.

IRACM

ASOP EU

Fight the fakes